{"disease":{"id":"malignant-melanomas","name":"malignant melanomas"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05928962","title":"An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}